American Society of Hirudotherapy

Primary Dysmenorrhea

Investigational for primary dysmenorrhea; one small randomized trial of leeches plus cupping versus an oral contraceptive pill reported lower pain scores.

Tier C — InvestigationalInvestigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Last Updated: November 10, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
Not FDA-cleared for primary dysmenorrhea. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
What evidence exists?
Tier C (investigational). One small randomized trial (40 women, 2022) found lower menstrual pain scores with leeches plus cupping than with a low-dose contraceptive pill; leeches were not tested alone, and no trial against NSAIDs or placebo was identified. Evidence-based first-line therapy is non-steroidal anti-inflammatory drugs (NSAIDs — ibuprofen, naproxen) started at first symptom or 1 to 2 days before expected menses, with combined oral contraceptives or levonorgestrel IUS for refractory cases or contraception needs. Heat application, regular exercise, and dietary measures are adjuncts. Secondary dysmenorrhea (endometriosis, fibroids, adenomyosis, pelvic inflammatory disease) requires identification and treatment of the underlying cause.
Main risks
  • Bleeding from bite sites for 6 to 24 hours after detachment
  • Bruising and tenderness over the abdomen and sacrum for 5 to 10 days
  • Local skin infection or, rarely, Aeromonas infection
  • Allergic reaction to leech saliva (uncommon)
  • Worsening of cramping in the first 24 hours
  • Small bite marks that usually fade over weeks to months (rarely a pale spot stays longer)
  • Missed diagnosis of secondary dysmenorrhea (endometriosis, fibroids, adenomyosis) if not investigated
  • Delay or replacement of NSAIDs or hormonal therapy
Who should not consider this
  • Patients who are pregnant or might be pregnant
  • Patients with active pelvic infection (PID, tubo-ovarian abscess)
  • Patients with secondary dysmenorrhea from structural pathology (endometriosis, fibroids) without specialty evaluation
  • Patients with severe acute pain different from typical menstrual cramping
  • Patients on anticoagulants, with hemophilia, or with anemia
  • Patients who have not tried evidence-based NSAIDs or hormonal options
What to ask your clinician
  • Has my dysmenorrhea been classified as primary or secondary?
  • Have I tried scheduled NSAIDs (ibuprofen 400 to 800 mg every 6 to 8 hours) started before menses?
  • Am I a candidate for combined oral contraceptives or levonorgestrel IUS?
  • Have I been screened for endometriosis (severe symptoms refractory to standard therapy may warrant evaluation)?
  • Have I tried heat application, regular exercise, and stress reduction?
  • Where exactly will leeches be placed — NEVER intravaginally?
  • What is the practitioner's experience and Aeromonas-prevention plan?
When to seek urgent care
  • Sudden severe pelvic pain with nausea, vomiting, fever, or fainting (possible ovarian torsion, ruptured cyst, or ectopic — call 911 or go to ER)
  • Heavy vaginal bleeding with positive pregnancy test (possible ectopic — emergency)
  • Severe pelvic pain with high fever and chills (possible PID)
  • Severe pain refractory to NSAIDs that is dramatically worse than usual menstrual cramps
  • Bleeding from a bite site lasting more than 24 to 48 hours
  • Fever above 38.0 C / 100.4 F or chills
  • Hives, throat tightness, or breathing difficulty

What this does NOT mean

  • This is not FDA-cleared for primary dysmenorrhea.
  • A single small trial of leeches combined with cupping does NOT establish that leeches alone work, or that they outperform NSAIDs or hormonal therapy.
  • Mechanism rationale (prostaglandin modulation) does NOT establish clinical efficacy.
  • Leech therapy is NEVER intravaginal — that placement is contraindicated.
  • Leech therapy is not a substitute for NSAIDs, hormonal therapy, or specialty evaluation for secondary dysmenorrhea.

Clinical Profile

Category
Gynecologic
ICD-10
N94.4, N94.5, N94.6
Safety tier
Low

Evidence Summary

One small randomized trial of leech therapy for primary dysmenorrhea was identified (Khodaverdian et al. 2022, Iran J Obstet Gynecol Infertil; 40 women): leeches plus cupping versus a low-dose oral contraceptive pill. Pain on a visual analogue scale was lower with leeches plus cupping at months 2 and 3 (P=0.048 and P=0.022) but not at month 1 (P=0.061). Leeches and cupping were given together, so the effect of leeches alone is unknown, and no NSAID-controlled or placebo-controlled trial was identified. Any use is investigational, with a proposed but unproven mechanism involving uterine prostaglandin modulation and local decongestion. Standard management (NSAIDs taken in the perimenstrual window, combined oral contraceptives, LNG-IUS) remains first-line. Leech therapy would only be reserved for refractory cases or those declining hormonal therapy, as an unproven option. Secondary dysmenorrhea (endometriosis, fibroids, adenomyosis) requires identification and treatment of the underlying pathology.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Pregnancy
  • Active pelvic infection
  • Secondary dysmenorrhea with structural pathology (treat underlying)

Related Conditions

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.